1
|
Lheureux S, Braunstein M and Oza AM:
Epithelial ovarian cancer: Evolution of management in the era of
precision medicine. CA Cancer J Clin. 69:280–304. 2019.PubMed/NCBI View Article : Google Scholar
|
2
|
Reid BM, Permuth JB and Sellers TA:
Epidemiology of ovarian cancer: A review. Cancer Biol Med. 14:9–32.
2017.PubMed/NCBI View Article : Google Scholar
|
3
|
Smith RA, Andrews KS, Brooks D, Fedewa SA,
Manassaram-Baptiste D, Saslow D, Brawley OW and Wender RC: Cancer
screening in the United States, 2018: A review of current American
cancer society guidelines and current issues in cancer screening.
CA Cancer J Clin. 68:297–316. 2018.PubMed/NCBI View Article : Google Scholar
|
4
|
Han CY, Patten DA, Richardson RB, Harper
ME and Tsang BK: Tumor metabolism regulating chemosensitivity in
ovarian cancer. Genes Cancer. 9:155–175. 2018.PubMed/NCBI View Article : Google Scholar
|
5
|
Sabio G, Arthur JS, Kuma Y, Peggie M, Carr
J, Murray-Tait V, Centeno F, Goedert M, Morrice NA and Cuenda A:
p38gamma regulates the localisation of SAP97 in the cytoskeleton by
modulating its interaction with GKAP. EMBO J. 24:1134–1145.
2005.PubMed/NCBI View Article : Google Scholar
|
6
|
Naisbitt S, Valtschanoff J, Allison DW,
Sala C, Kim E, Craig AM, Weinberg RJ and Sheng M: Interaction of
the postsynaptic density-95/guanylate kinase domain-associated
protein complex with a light chain of myosin-V and dynein. J
Neurosci. 20:4524–4534. 2000.PubMed/NCBI View Article : Google Scholar
|
7
|
Tong J, Yang H, Eom SH, Chun C and Im YJ:
Structure of the GH1 domain of guanylate kinase-associated protein
from Rattus norvegicus. Biochem Biophys Res Commun. 452:130–135.
2014.PubMed/NCBI View Article : Google Scholar
|
8
|
Minocherhomji S, Hansen C, Kim HG, Mang Y,
Bak M, Guldberg P, Papadopoulos N, Eiberg H, Doh GD, Møllgård K, et
al: Epigenetic remodelling and dysregulation of DLGAP4 is linked
with early-onset cerebellar ataxia. Hum Mol. 23:6163–6176.
2014.PubMed/NCBI View Article : Google Scholar
|
9
|
Ryu S, Oh S, Cho EY, Nam HJ, Yoo JH, Park
T, Joo YH, Kwon JS and Hong KS: Interaction between genetic
variants of DLGAP3 and SLC1A1 affecting the risk of atypical
antipsychotics-induced obsessive-compulsive symptoms. Am J Med
Genet B Neuropsychiatr Genet. 156B:949–959. 2011.PubMed/NCBI View Article : Google Scholar
|
10
|
Kajimoto Y, Shirakawa O, Lin XH, Hashimoto
T, Kitamura N, Murakami N, Takumi T and Maeda K: Synapse-associated
protein 90/postsynaptic density-95-associated protein (SAPAP) is
expressed differentially in phencyclidine-treated Rats and is
increased in the nucleus accumbens of patients with schizophrenia.
Neuropsychopharmacology. 28:1831–1839. 2003.PubMed/NCBI View Article : Google Scholar
|
11
|
Tang ZY, Ye SL, Liu YK, Qin LX, Sun HC, Ye
QH, Wang L, Zhou J, Qiu SJ, Li Y, et al: A decade's studies on
metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol.
130:187–196. 2004.PubMed/NCBI View Article : Google Scholar
|
12
|
Stangeland B, Mughal AA, Grieg Z, Sandberg
CJ, Joel M, Nygård S, Meling T, Murrell W, Vik Mo EO and Langmoen
IA: Combined expressional analysis, bioinformatics and targeted
proteomics identify new potential therapeutic targets in
glioblastoma stem cells. Oncotarget. 6:26192–26215. 2015.PubMed/NCBI View Article : Google Scholar
|
13
|
Tsou AP, Yang CW, Huang CY, Yu RC, Lee YC,
Chang CW, Chen BR, Chung YF, Fann MJ, Chi CW, et al: Identification
of a novel cell cycle regulated gene, HURP, overexpressed in human
hepatocellular carcinoma. Oncogene. 22:298–307. 2003.PubMed/NCBI View Article : Google Scholar
|
14
|
Hatfield KJ, Reikvam H and Bruserud O:
Identification of a subset of patients with acute myeloid leukemia
characterized by long-term in vitro proliferation and altered cell
cycle regulation of the leukemic cells. Expert Opin Ther Targets.
18:1237–1251. 2014.PubMed/NCBI View Article : Google Scholar
|
15
|
Weinberger P, Ponny SR, Xu H, Bai S,
Smallridge R, Copland J and Sharma A: Cell cycle M-phase genes are
highly upregulated in anaplastic thyroid carcinoma. Thyroid.
27:236–252. 2017.PubMed/NCBI View Article : Google Scholar
|
16
|
Schneider MA, Christopoulos P, Muley T,
Warth A, Klingmueller U, Thomas M, Herth FJ, Dienemann H, Mueller
NS, Theis F and Meister M: AURKA, DLGAP5, TPX2, KIF11 and CKAP5:
Five specific mitosis-associated genes correlate with poor
prognosis for non-small cell lung cancer patients. Int J Oncol.
50:365–372. 2017.PubMed/NCBI View Article : Google Scholar
|
17
|
Shi YX, Yin JY, Shen Y, Zhang W, Zhou HH
and Liu ZQ: Genome-scale analysis identifies NEK2, DLGAP5 and ECT2
as promising diagnostic and prognostic biomarkers in human lung
cancer. Sci Rep. 7(8072)2017.PubMed/NCBI View Article : Google Scholar
|
18
|
Zhou Z, Cheng Y, Jiang Y, Liu S, Zhang M,
Liu J and Zhao Q: Ten hub genes associated with progression and
prognosis of pancreatic carcinoma identified by co-expression
analysis. Int J Biol Sci. 14:124–136. 2018.PubMed/NCBI View Article : Google Scholar
|
19
|
Zhou Y, Yang L, Zhang X, Chen R, Chen X,
Tang W and Zhang M: Identification of potential biomarkers in
glioblastoma through bioinformatic analysis and evaluating their
prognostic value. Biomed Res Int. 2019(6581576)2019.PubMed/NCBI View Article : Google Scholar
|
20
|
Liao W, Liu W, Yuan Q, Liu X, Ou Y, He S,
Yuan S, Qin L, Chen Q, Nong K, et al: Silencing of DLGAP5 by siRNA
significantly inhibits the proliferation and invasion of
hepatocellular carcinoma cells. PLoS One. 8(e80789)2013.PubMed/NCBI View Article : Google Scholar
|
21
|
Kuo TC, Chang PY, Huang SF, Chou CK and
Chao CC: Knockdown of HURP inhibits the proliferation of
hepacellular carcinoma cells via downregulation of gankyrin and
accumulation of p53. Biochem Pharmacol. 83:758–768. 2012.PubMed/NCBI View Article : Google Scholar
|
22
|
Liu J, Meng H, Li S, Shen Y, Wang H, Shan
W, Qiu J, Zhang J and Cheng W: Identification of potential
biomarkers in association with progression and prognosis in
epithelial ovarian cancer by integrated bioinformatics analysis.
Front Genet. 10(1031)2019.PubMed/NCBI View Article : Google Scholar
|
23
|
Shen J, Yu S, Sun X, Yin M, Fei J and Zhou
J: Identification of key biomarkers associated with development and
prognosis in patients with ovarian carcinoma: Evidence from
bioinformatic analysis. J Ovarian Res. 12(110)2019.PubMed/NCBI View Article : Google Scholar
|
24
|
Yoshihara K, Tajima A, Komata D, Yamamoto
T, Kodama S, Fujiwara H, Suzuki M, Onishi Y, Hatae M, Sueyoshi K,
et al: Gene expression profiling of advanced-stage serous ovarian
cancers distinguishes novel subclasses and implicates ZEB2 in tumor
progression and prognosis. Cancer Sci. 100:1421–1428.
2009.PubMed/NCBI View Article : Google Scholar
|
25
|
Welsh JB, Zarrinkar PP, Sapinoso LM, Kern
SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA and Hampton GM:
Analysis of gene expression profiles in normal and neoplastic
ovarian tissue samples identifies candidate molecular markers of
epithelial ovarian cancer. Proc Natl Acad Sci USA. 98:1176–1181.
2001.PubMed/NCBI View Article : Google Scholar
|
26
|
Bonome T, Levine DA, Shih J, Randonovich
M, Pise-Masison CA, Bogomolniy F, Ozbun L, Brady J, Barrett JC,
Boyd J and Birrer MJ: A gene signature predicting for survival in
suboptimally debulked patients with ovarian cancer. Cancer Res.
68:5478–5486. 2008.PubMed/NCBI View Article : Google Scholar
|
27
|
Adib TR, Henderson S, Perrett C, Hewitt D,
Bourmpoulia D, Ledermann J and Boshoff C: Predicting biomarkers for
ovarian cancer using gene-expression microarrays. Br J Cancer.
90:686–692. 2004.PubMed/NCBI View Article : Google Scholar
|
28
|
Lu KH, Patterson AP, Wang L, Marquez RT,
Atkinson EN, Baggerly KA, Ramoth LR, Rosen DG, Liu J, Hellstrom I,
et al: Selection of potential markers for epithelial ovarian cancer
with gene expression arrays and recursive descent partition
analysis. Clin Cancer Res. 10:3291–3300. 2004.PubMed/NCBI View Article : Google Scholar
|
29
|
Chang ML, Lin SM and Yeh CT: HURP
expression-assisted risk scores identify prognosis distinguishable
subgroups in early stage liver cancer. PLoS One.
6(e26323)2011.PubMed/NCBI View Article : Google Scholar
|
30
|
Huang YL, Chiu AW, Huan SK, Wang YC, Ju JP
and Lu CL: Prognostic significance of hepatoma-up-regulated protein
expression in patients with urinary bladder transitional cell
carcinoma. Anticancer Res. 23:2729–2733. 2003.PubMed/NCBI
|
31
|
Chiu AW, Huang YL, Huan SK, Wang YC, Ju
JP, Chen MF and Chou CK: Potential molecular marker for detecting
transitional cell carcinoma. Urology. 60:181–185. 2002.PubMed/NCBI View Article : Google Scholar
|
32
|
Brązert M, Kranc W, Chermuła B, Kowalska
K, Jankowski M, Celichowski P, Jeseta M, Piotrowska-Kempisty H,
Pawelczyk L, Zabel M, et al: Human ovarian granulosa cells isolated
during an IVF procedure exhibit differential expression of genes
regulating cell division and mitotic spindle formation. J Clin Med.
8(2026)2019.PubMed/NCBI View Article : Google Scholar
|
33
|
Zhang W, Gao L, Wang C, Wang S, Sun D, Li
X, Liu M, Qi Y, Liu J and Lin B: Combining bioinformatics and
experiments to identify and verify key genes with prognostic values
in endometrial carcinoma. J Cancer. 11:716–732. 2020.PubMed/NCBI View Article : Google Scholar
|
34
|
Branchi V, Garcia SA, Radhakrishnan P,
Győrffy B, Hissa B, Schneider M, Reißfelder C and Schölch S:
Prognostic value of DLGAP5 in colorectal cancer. Int J Colorectal
Dis. 34:1455–1465. 2019.PubMed/NCBI View Article : Google Scholar
|
35
|
Sterlacci W, Tzankov A, Veits L, Zelger B,
Bihl MP, Foerster A, Augustin F, Fiegl M and Savic S: A
comprehensive analysis of p16 expression, gene status, and promoter
hypermethylation in surgically resected non-small cell lung
carcinomas. J Thorac Oncol. 6:1649–1657. 2011.PubMed/NCBI View Article : Google Scholar
|
36
|
Singhal S, Amin KM, Kruklitis R, DeLong P,
Friscia ME, Litzky LA, Putt ME, Kaiser LR and Albelda SM:
Alterations in cell cycle genes in early stage lung adenocarcinoma
identified by expression profiling. Cancer Biol Ther. 2:291–298.
2003.PubMed/NCBI View Article : Google Scholar
|
37
|
Santarella RA, Koffa MD, Tittmann P, Gross
H and Hoenger A: HURP wraps microtubule ends with an additional
tubulin sheet that has a novel conformation of tubulin. J Mol Biol.
365:1587–1595. 2007.PubMed/NCBI View Article : Google Scholar
|
38
|
Koffa MD, Casanova CM, Santarella R,
Köcher T, Wilm M and Mattaj IW: HURP is part of a Ran-dependent
complex involved in spindle formation. Curr Biol. 16:743–754.
2006.PubMed/NCBI View Article : Google Scholar
|
39
|
Casanova CM, Rybina S, Yokoyama H,
Karsenti E and Mattaj IW: Hepatoma up-regulated protein is required
for chromatin-induced microtubule assembly independently of TPX2.
Mol Biol Cell. 19:4900–4908. 2008.PubMed/NCBI View Article : Google Scholar
|
40
|
Yu CT, Hsu JM, Lee YC, Tsou AP, Chou CK
and Huang CY: Phosphorylation and stabilization of HURP by
Aurora-A: Implication of HURP as a transforming target of Aurora-A.
Mol Cell Biol. 25:5789–5800. 2005.PubMed/NCBI View Article : Google Scholar
|
41
|
Hsu JM, Lee YC, Yu CT and Huang CY: Fbx7
functions in the SCF complex regulating Cdk1-cyclin
B-phosphorylated hepatoma up-regulated protein (HURP) proteolysis
by a proline-rich region. J Biol Chem. 279:32592–32602.
2004.PubMed/NCBI View Article : Google Scholar
|
42
|
Zhang X, Pan Y, Fu H and Zhang J:
Nucleolar and spindle associated protein 1 (NUSAP1) inhibits cell
proliferation and enhances susceptibility to epirubicin in invasive
breast cancer cells by regulating cyclin D kinase (CDK1) and DLGAP5
expression. Med Sci Monit. 24:8553–8564. 2018.PubMed/NCBI View Article : Google Scholar
|
43
|
Hassan M, El Khattouti A, Ejaeidi A, Ma T,
Day WA, Espinoza I, Vijayakumar S and Gomez CR: Elevated expression
of hepatoma up-regulated protein inhibits γ-irradiation-induced
apoptosis of prostate cancer cells. J Cell Biochem. 117:1308–1318.
2016.PubMed/NCBI View Article : Google Scholar
|